{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Ftransmitted-resistance-RgkQV6pz","width":444,"version":"1.0","type":"rich","title":"Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/4b0ca812-1cf1-4eeb-b12c-6b1ea15b71e9/cliniciansxchange-pod193-transmitted-resistance-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/4713a1df-62eb-4ad3-b0a1-5949ec8bcee3\" height=\"200\" width=\"100%\" title=\"Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen as John D. Baxter, MD, shares the latest data and recommendations for initiating ART in patients with transmitted\nantiretroviral drug resistance."}